GB9922709D0 - Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases - Google Patents

Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases

Info

Publication number
GB9922709D0
GB9922709D0 GBGB9922709.2A GB9922709A GB9922709D0 GB 9922709 D0 GB9922709 D0 GB 9922709D0 GB 9922709 A GB9922709 A GB 9922709A GB 9922709 D0 GB9922709 D0 GB 9922709D0
Authority
GB
United Kingdom
Prior art keywords
biarylbutyric
substituted
treatment
acid derivatives
respiratory diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9922709.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Priority to GBGB9922709.2A priority Critical patent/GB9922709D0/en
Publication of GB9922709D0 publication Critical patent/GB9922709D0/en
Priority to JP2000592250A priority patent/JP2002534404A/en
Priority to TR2001/01970T priority patent/TR200101970T2/en
Priority to BR9916669-0A priority patent/BR9916669A/en
Priority to PCT/EP1999/010110 priority patent/WO2000040539A1/en
Priority to US09/869,668 priority patent/US6900194B1/en
Priority to EP99963582A priority patent/EP1140768A1/en
Priority to IL14359499A priority patent/IL143594A0/en
Priority to CA002356053A priority patent/CA2356053A1/en
Priority to CN99816404A priority patent/CN1337932A/en
Priority to KR1020017008314A priority patent/KR20010101325A/en
Priority to AU19825/00A priority patent/AU1982500A/en
Priority to PE1999001333A priority patent/PE20001339A1/en
Priority to ARP990106795A priority patent/AR035472A1/en
Priority to UY25888A priority patent/UY25888A1/en
Priority to CO99081622A priority patent/CO5261506A1/en
Priority to HK02105193.2A priority patent/HK1043981A1/en
Ceased legal-status Critical Current

Links

GBGB9922709.2A 1998-12-30 1999-09-24 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases Ceased GB9922709D0 (en)

Priority Applications (17)

Application Number Priority Date Filing Date Title
GBGB9922709.2A GB9922709D0 (en) 1999-09-24 1999-09-24 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases
AU19825/00A AU1982500A (en) 1998-12-30 1999-12-20 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases
CA002356053A CA2356053A1 (en) 1998-12-30 1999-12-20 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases
KR1020017008314A KR20010101325A (en) 1998-12-30 1999-12-20 Use of Substituted 4-Biarylbutyric and 5-Biarylpentanoic Acid Derivatives as Matrix Metalloprotease Inhibitors for the Treatment of Respiratory Diseases
BR9916669-0A BR9916669A (en) 1998-12-30 1999-12-20 Use of derivatives of substituted 4-biarylbutyric and 5-biarylpentanoic acids as matrix metalloprotease inhibitors for the treatment of respiratory diseases
PCT/EP1999/010110 WO2000040539A1 (en) 1998-12-30 1999-12-20 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases
US09/869,668 US6900194B1 (en) 1998-12-30 1999-12-20 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases
EP99963582A EP1140768A1 (en) 1998-12-30 1999-12-20 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases
IL14359499A IL143594A0 (en) 1998-12-30 1999-12-20 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases
JP2000592250A JP2002534404A (en) 1998-12-30 1999-12-20 Use of substituted 4-biarylbutyric acid and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases
CN99816404A CN1337932A (en) 1998-12-30 1999-12-20 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treamtent of respiratory diseases
TR2001/01970T TR200101970T2 (en) 1998-12-30 1999-12-20 The use of substituted 4-biarylbutyric and 5-biarylpentanoic acid t revs as matrix metalloprotease inhibitors in the treatment of respiratory diseases
ARP990106795A AR035472A1 (en) 1998-12-30 1999-12-28 USE OF 4-BIARILBUTIRIC AND 5-BIARILPENTANOIC ACID DERIVATIVES REPLACED AS INHIBITORS OF MATRIX METALOPROTEASE FOR THE TREATMENT OF RESPIRATORY DISEASES, COMPOUNDS AND COMPOSITIONS THAT INCLUDE THEM
PE1999001333A PE20001339A1 (en) 1998-12-30 1999-12-28 USE OF DERIVATIVES OF 4-BIARYLBUTYRIC ACID AND 5-BIARYLPENTANOIC SUBSTITUTE AS INHIBITORS OF MATRIX METALOPROTEASE FOR THE TREATMENT OF RESPIRATORY DISEASES
UY25888A UY25888A1 (en) 1998-12-30 1999-12-30 DERIVATIVES OF 4-BIARILBUTIRICO AND 5-BIARILPENTANOICO ACID SUBSTITUTES USEFUL AS MATRIX METALPROTEASE INHIBITORS FOR THE TREATMENT OF RESPIRATORY DISEASES
CO99081622A CO5261506A1 (en) 1998-12-30 1999-12-30 USE OF 4-BIARILBUTIRICO AND 5-BIARILPENTANOICO DERIVATIVES REPLACED AS INHIBITORS OF MATRIX METALOPROTEASE FOR THE TREATMENT OF RESPIRATORY DISEASES
HK02105193.2A HK1043981A1 (en) 1998-12-30 2002-07-12 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9922709.2A GB9922709D0 (en) 1999-09-24 1999-09-24 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases

Publications (1)

Publication Number Publication Date
GB9922709D0 true GB9922709D0 (en) 1999-11-24

Family

ID=10861598

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9922709.2A Ceased GB9922709D0 (en) 1998-12-30 1999-09-24 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases

Country Status (1)

Country Link
GB (1) GB9922709D0 (en)

Similar Documents

Publication Publication Date Title
ZA200707934B (en) Thereapeutic formulations for the treatment of beta-amyloid related diseases
HUP0003863A3 (en) Alpha-sulfonylamino hidroxamic acid inhibitors of matrix metalloproteinases for the treatment of peripheral or central nervous system disorders
IL143594A0 (en) Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases
IL167250A (en) Chirale oxazole-arylpropionic acid derivatives, compositions comprising thereof and their use in the preparation of medicaments for the treatment of ppar alpha/ ppar gamma agonists-modulated diseases
PT1487828E (en) Morpholinyl-urea derivatives for use of the treatment of inflamatory diseases
AU2002220735A1 (en) Substituted derivatives of aminofuran-2-yl-acetic acid and aminothien-2-yl-acetic acid and the use thereof for treating migraines and pain
HUP0303041A3 (en) Substituted derivatives of aminofuran-2-yl-acetic acid and aminothien-2-yl-acetic acid and the use thereof for treating migraines and pain
HRP20020893A2 (en) Formulations containing a glucocorticoid drug for the treatment of bronchopulmonary diseases
HK1044536A1 (en) Crystals of an oxyiminoalkanoic acid derivative and their use as antidiabetics
HUP0104963A3 (en) Compositions for the treatment of skin diseases
GB9929497D0 (en) Improved amino acid mixtures for the treatment and/or management of certain diseases
HK1057332A1 (en) Use of 3-benzoylphenylacetic acid derivatives for the treatment of retinal disorders
HK1045260B (en) Heteroatom-interrupted analogs of 15-hydroxyeicosatetraenoic acid and methods of use
GB0111594D0 (en) Pipecolnic acid derivatives method of manufacturing the same and therapeutic agents containing these compounds
AU9545701A (en) Use of carp inhibitors for the treatment of heart diseases
AU7653600A (en) Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of multiple sclerosis
EP1150669A4 (en) L-arginine based formulations for treating diseases and methods of using same
HUP0203270A3 (en) Hydroxamic acid derivative as inhibitor of the formation of human cd23, process for its preparation and pharmaceutical compositions containing the same
GB9922709D0 (en) Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases
AU2900100A (en) Methods for inhibiting cathepsin k activity for the treatment of diseases related to bone loss
GB9828845D0 (en) Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases
AU2001273801A1 (en) Dehydrobaimuxinol derivatives use as medicaments for treating or preventing regressive diseases of brain
AU4101900A (en) Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of cerebral diseases
HUP0301971A3 (en) Uses of thaliporphine or its derivatives for producing pharmaceutical compositions suitable for treating cardiac diseases and the compounds
AU2908501A (en) Combination therapy for the treatment of inflammatory and respiratory diseases

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)